Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emoclot for Immune Tolerance Induction in Hemophilia A
NCT02479087Phase 4Unknown
- Sponsor
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
- Start
- Jan 2015
- Primary completion
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 4 trial of Emoclot in hemophilia A, sponsored by Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. Status: unknown.
02
Drugs
Emoclot
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02479087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02479087.